Affyimmune Therapeutics

Limited information available

placeNatick, Massachusetts, United States calendar_todayFounded 2016 groups26 employees language affyimmune.com

Innovation

7 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 47 times.

YearFilings
20211
20221
20232
20242
20255

Investor mix

1 investor on record; lead investors include ORI Capital.

Investor typeCountShare
Venture capital1100%
Coming soon